Margoni, Monica
Preziosa, Paolo
Filippi, Massimo
Rocca, Maria A. http://orcid.org/0000-0003-2358-4320
Article History
Received: 7 July 2021
Revised: 2 August 2021
Accepted: 3 August 2021
First Online: 11 August 2021
Declarations
:
: M. Margoni reports grants and personal fees from Sanofi Genzyme, Merck Serono, Novartis and Almirall. She was awarded a MAGNIMS-ECTRIMS fellowship in 2020. P. Preziosa received speaker honoraria from Biogen Idec, Novartis, Merck Serono and ExceMED. He is supported by a senior research fellowship FISM—Fondazione Italiana Sclerosi Multipla—cod. 2019/BS/009 and financed or co-financed with the ‘5 per mille’ public funding. M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i> and Associate Editor of <i>Radiology</i>, <i>Human Brain Mapping</i> and <i>Neurological Sciences</i>, received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries, and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). M.A. Rocca received speaker honoraria from Bayer, Biogen, Bristol Myers Squibb, Celgene, Genzyme, Merck Serono, Novartis, Roche, and Teva, and receives research support from the MS Society of Canada and Fondazione Italiana Sclerosi Multipla.
Free to read: This content has been made available to all.